Intraoperative Identification of Liver Cancer Microfoci Using a Targeted Near-Infrared Fluorescent Probe for Imaging-Guided Surgery

Difficulties in the highly sensitive detection of tumour microfoci represent a critical obstacle toward improved surgical intervention in liver cancer. Conventional preoperative imaging methods and surgeons’ subjective experience are limited by their inability to effectively detect tumour lesions measuring less than 2 mm; however, intraoperative fluorescence molecular imaging may overcome this limitation. Here, we synthesised an arginine-glycine-aspartic acid (RGD)-conjugated mesoporous silica nanoparticle (MSN) highly loaded with indocyanine green (ICG) dye that could accurately delineate liver cancer margins and provide excellent tumour-to-normal tissue contrast intraoperatively. The increased ICG loading capacity and tumour specificity enabled the identification of residual microtumours and satellite lesions measuring less than 1 mm in living mice. Histological analysis validated the sensitivity and accuracy of this approach. We believe this technique utilising a new fluorescent nanoprobe with intraoperative optical imaging may offer a more sensitive and accurate method for liver cancer resection guidance, resulting in better surgical outcomes.

[1]  P. Low,et al.  Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results , 2011, Nature Medicine.

[2]  Peter L. Choyke,et al.  Rapid Cancer Detection by Topically Spraying a γ-Glutamyltranspeptidase–Activated Fluorescent Probe , 2011, Science Translational Medicine.

[3]  Cornelis J H van de Velde,et al.  Near‐infrared fluorescence‐guided resection of colorectal liver metastases , 2013, Cancer.

[4]  Juan L. Vivero-Escoto,et al.  Silica-based nanoprobes for biomedical imaging and theranostic applications. , 2012, Chemical Society reviews.

[5]  Sangeeta N. Bhatia,et al.  Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes , 2014, Proceedings of the National Academy of Sciences.

[6]  Vasilis Ntziachristos,et al.  Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies , 2011, The Journal of Nuclear Medicine.

[7]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[8]  L. Chirieac,et al.  Identification of metastatic nodal disease in a phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non-small cell lung cancer using near-infrared imaging. , 2013, The Journal of thoracic and cardiovascular surgery.

[9]  Linlin Li,et al.  Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery , 2012, Advanced materials.

[10]  Eric C. Carnes,et al.  Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. , 2013, Accounts of chemical research.

[11]  Erkki Ruoslahti,et al.  αv Integrins as receptors for tumor targeting by circulating ligands , 1997, Nature Biotechnology.

[12]  Jiashing Yu,et al.  Liver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres , 2014, International journal of nanomedicine.

[13]  P. Francis,et al.  Strategies for the discovery and development of therapies for metastatic breast cancer , 2012, Nature Reviews Drug Discovery.

[14]  Mitsuharu Miwa,et al.  Sentinel Node Mapping Guided by Indocyanine Green Fluorescence Imaging in Gastric Cancer , 2009, Annals of surgery.

[15]  Jesse V. Jokerst,et al.  Intracellular Aggregation of Multimodal Silica Nanoparticles for Ultrasound-Guided Stem Cell Implantation , 2013, Science Translational Medicine.

[16]  Jan Grimm,et al.  Silica Nanoparticles as Substrates for Chelator-free Labeling of Oxophilic Radioisotopes , 2015, Nano letters.

[17]  V. Ntziachristos,et al.  Indocyanine Green Enables Near-Infrared Fluorescence Imaging of Lipid-Rich, Inflamed Atherosclerotic Plaques , 2011, Science Translational Medicine.

[18]  D. Woodfield Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[19]  Dong Chen,et al.  Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. , 2011, ACS nano.

[20]  Linlin Li,et al.  Facile and Scalable Synthesis of Tailored Silica “Nanorattle” Structures , 2009 .

[21]  Jie Tian,et al.  In vivo nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging , 2015, Nature Communications.

[22]  Osamu Ishikawa,et al.  A novel image‐guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation , 2009, Journal of surgical oncology.

[23]  Merlijn Hutteman,et al.  The clinical use of indocyanine green as a near‐infrared fluorescent contrast agent for image‐guided oncologic surgery , 2011, Journal of surgical oncology.

[24]  Lu Wang,et al.  First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot study. , 2013, Translational research : the journal of laboratory and clinical medicine.

[25]  O. Feron,et al.  Tumor-Penetrating Peptides: A Shift from Magic Bullets to Magic Guns , 2010, Science Translational Medicine.

[26]  N. S. van den Berg,et al.  Multimodal Surgical Guidance during Sentinel Node Biopsy for Melanoma: Combined Gamma Tracing and Fluorescence Imaging of the Sentinel Node through Use of the Hybrid Tracer Indocyanine Green-(99m)Tc-Nanocolloid. , 2015, Radiology.

[27]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[28]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[29]  Hisataka Kobayashi,et al.  Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications. , 2011, Accounts of chemical research.

[30]  John V Frangioni,et al.  New technologies for human cancer imaging. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Srikanth K. Iyer,et al.  Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. , 2011, The Journal of clinical investigation.

[32]  D. M. Olive,et al.  Integrin αvβ3-Targeted IRDye 800CW Near-Infrared Imaging of Glioblastoma , 2012, Clinical Cancer Research.

[33]  Dong Choon Hyun,et al.  Engineered nanoparticles for drug delivery in cancer therapy. , 2014, Angewandte Chemie.

[34]  R. Tsien,et al.  Fluorescence-guided surgery with live molecular navigation — a new cutting edge , 2013, Nature Reviews Cancer.

[35]  Xiang Liang,et al.  In Vivo Cancer Dual-Targeting and Dual-Modality Imaging with Functionalized Quantum Dots , 2015, The Journal of Nuclear Medicine.

[36]  E. Loveman,et al.  The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation. , 2014, Health technology assessment.

[37]  R. Tsien,et al.  Dual Targeting of Integrin αvβ3 and Matrix Metalloproteinase-2 for Optical Imaging of Tumors and Chemotherapeutic Delivery , 2014, Molecular Cancer Therapeutics.

[38]  Kwangmeyung Kim,et al.  Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. , 2011, ACS nano.

[39]  Lynda Wyld,et al.  The evolution of cancer surgery and future perspectives , 2015, Nature Reviews Clinical Oncology.

[40]  J. Frangioni,et al.  Effective Low-dose Escalation of Indocyanine Green for Near-infrared Fluorescent Sentinel Lymph Node Mapping in Melanoma , 2013, Annals of Surgical Oncology.

[41]  S. Achilefu,et al.  Binocular Goggle Augmented Imaging and Navigation System provides real-time fluorescence image guidance for tumor resection and sentinel lymph node mapping , 2015, Scientific Reports.

[42]  Jinzuo Ye,et al.  Intraoperative Imaging-Guided Cancer Surgery: From Current Fluorescence Molecular Imaging Methods to Future Multi-Modality Imaging Technology , 2014, Theranostics.

[43]  E. Winer,et al.  International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? , 2010, Journal of the National Cancer Institute.

[44]  N. Bander,et al.  Targeting the Internal Epitope of Prostate-Specific Membrane Antigen with 89Zr-7E11 Immuno-PET , 2011, The Journal of Nuclear Medicine.

[45]  D. Breen,et al.  The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation. , 2014, Health technology assessment.

[46]  Jinzuo Ye,et al.  Increased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probes , 2015, Scientific Reports.